Stock giving Positive news
#BhartiAirtel
#DrReddy's
#Tatacons
#adanient
#bajajhealth
#iiflwealth
#careratings
#angelbroking
#BhartiAirtel
#DrReddy's
#Tatacons
#adanient
#bajajhealth
#iiflwealth
#careratings
#angelbroking
Stocks To Watch
• Godrej Properties: Is seeing strong revival in housing sales after the second wave of the pandemic impacted first-quarter results, Executive Chairman Pirojshah Godrej said. Revival in sales post first quarter and large number of planned project launches will help the company to record higher sales growth in the current financial year, compared to last year, Godrej said. The company is also seeking to invest in large land deals in the near future after raising capital earlier this year. It plans to use a significant amount of this capital for expanding its presence in Mumbai.
• Tata Steel: Global rating agency S&P has upgraded the company’s long-term rating to BB from BB-; outlook remains stable. S&P expects Tata Steel’s debt levels to decline materially over the next two years on the company’s commitment to deleverage, supported by strong operating cash flows. It expects Tata Steel’s adjusted debt to decline by more than 30% by March 2023 from its March 2021 level.
• GR Infraprojects: Received Letter of Acceptance from Bangalore Metro Rail Corporation for construction of 5 metro stations, elevated structures, road widening and allied works. The contract price is Rs 365 crore. The project is expected to be completed in 21 months from signing of contract agreement.
• Natco Pharma: Transferred the Lenalidomide Capsules ANDA to Arrow International Limited as per an earlier agreement between the parties. Arrow International is the marketing partner of Natco for this product in the U.S. market. The ANDA was approved by U.S. FDA in May 2021.
• Tata Consultancy Services: Rich Products has selected the company for intelligent supply chain modernisation to improve operations and agility. TCS will help the global food company harness cloud-based AI and ML platform to enhance integrated planning and agility in meeting changing customer demands.
• Linde India: Signed a Business Transfer Agreement with HPS Gases Ltd., Vadodara to acquire its entire packaged gases business along with certain distribution assets with effect from November 1, for an aggregate cash consideration of Rs 27.5 crore.
• Balaji Amines: To set up a new plant to manufacture Acetonitrile. The plant will cost company approximately Rs 80 crore and will be set up in 12 to 18 months. This will also increase the company’s capacity by 16,500 TPA from 9,000 TPA.
• Dr. Reddy's Laboratories: Re-launched Naproxen Sodium Tablets USP, 220 mg, the store-brand equivalent of Aleve, in the U.S. market, as approved by the U.S. Food and Drug Administration. Naproxen Sodium Tablets is an over-the-counter nonsteroidal anti-inflammatory drug used as a pain reliever and fever reducer.
• Canara Bank: To raise up to Rs 2,500 crore through QIP/Rights Issue/any other approved means during the financial year 2021-22. The bank will also appropriate accumulated losses of Rs 18,495.30 crore from Share Premium Account.
• Oswal Leasing: To consider right issue on August 12.
• Birla Corporation: The Board of Directors of RCCPL, a wholly owned subsidiary, has approved revision in the capital expenditure from Rs 2,450 crore to Rs 2,744 crore for setting up of a 3.90 million tons Greenfield Integrated Cement Plant at Mukutban (Maharashtra) with 40 MW Captive Power Plant and 10.60 MW Waste Heat Recovery System, on account of the revision in project commencement schedule and other factors including increase in commodity prices. The board has also approved restructuring of the scope of second phase expansion of existing capacity of grinding cement plant at Kundanganj (Uttar Pradesh). Expansion in capacity as per the revised scope stands at 0.7 million tons. The project cost stands reduced to Rs 154 crore.
• Godrej Properties: Is seeing strong revival in housing sales after the second wave of the pandemic impacted first-quarter results, Executive Chairman Pirojshah Godrej said. Revival in sales post first quarter and large number of planned project launches will help the company to record higher sales growth in the current financial year, compared to last year, Godrej said. The company is also seeking to invest in large land deals in the near future after raising capital earlier this year. It plans to use a significant amount of this capital for expanding its presence in Mumbai.
• Tata Steel: Global rating agency S&P has upgraded the company’s long-term rating to BB from BB-; outlook remains stable. S&P expects Tata Steel’s debt levels to decline materially over the next two years on the company’s commitment to deleverage, supported by strong operating cash flows. It expects Tata Steel’s adjusted debt to decline by more than 30% by March 2023 from its March 2021 level.
• GR Infraprojects: Received Letter of Acceptance from Bangalore Metro Rail Corporation for construction of 5 metro stations, elevated structures, road widening and allied works. The contract price is Rs 365 crore. The project is expected to be completed in 21 months from signing of contract agreement.
• Natco Pharma: Transferred the Lenalidomide Capsules ANDA to Arrow International Limited as per an earlier agreement between the parties. Arrow International is the marketing partner of Natco for this product in the U.S. market. The ANDA was approved by U.S. FDA in May 2021.
• Tata Consultancy Services: Rich Products has selected the company for intelligent supply chain modernisation to improve operations and agility. TCS will help the global food company harness cloud-based AI and ML platform to enhance integrated planning and agility in meeting changing customer demands.
• Linde India: Signed a Business Transfer Agreement with HPS Gases Ltd., Vadodara to acquire its entire packaged gases business along with certain distribution assets with effect from November 1, for an aggregate cash consideration of Rs 27.5 crore.
• Balaji Amines: To set up a new plant to manufacture Acetonitrile. The plant will cost company approximately Rs 80 crore and will be set up in 12 to 18 months. This will also increase the company’s capacity by 16,500 TPA from 9,000 TPA.
• Dr. Reddy's Laboratories: Re-launched Naproxen Sodium Tablets USP, 220 mg, the store-brand equivalent of Aleve, in the U.S. market, as approved by the U.S. Food and Drug Administration. Naproxen Sodium Tablets is an over-the-counter nonsteroidal anti-inflammatory drug used as a pain reliever and fever reducer.
• Canara Bank: To raise up to Rs 2,500 crore through QIP/Rights Issue/any other approved means during the financial year 2021-22. The bank will also appropriate accumulated losses of Rs 18,495.30 crore from Share Premium Account.
• Oswal Leasing: To consider right issue on August 12.
• Birla Corporation: The Board of Directors of RCCPL, a wholly owned subsidiary, has approved revision in the capital expenditure from Rs 2,450 crore to Rs 2,744 crore for setting up of a 3.90 million tons Greenfield Integrated Cement Plant at Mukutban (Maharashtra) with 40 MW Captive Power Plant and 10.60 MW Waste Heat Recovery System, on account of the revision in project commencement schedule and other factors including increase in commodity prices. The board has also approved restructuring of the scope of second phase expansion of existing capacity of grinding cement plant at Kundanganj (Uttar Pradesh). Expansion in capacity as per the revised scope stands at 0.7 million tons. The project cost stands reduced to Rs 154 crore.
Stocks To Watch
• Vodafone Idea: Kumar Mangalam Birla has stepped down as chairman of the company. The board accepted Birla’s request to step down as non-executive director and non-executive chairman of Vodafone Idea from August 4. Board has elected Himanshu Kapania as the non-executive chairman. Kapania is a nominee of the Aditya Birla Group. Board also appointed Sushil Agarwal, a nominee of Aditya Birla Group, as an additional director.
• SBI Life Insurance Company: CA Emerald Investments, an affiliate of Carlyle Group, to sell its entire 1.9% stake in SBI Life Insurance Company. It will sell 1.90 crore shares at Rs 1,130- Rs 1,136.85 apiece, as per term sheet. At the lower end, CA Emerald Investments will be able to raise Rs 2,147 crore ($289.4 million).
• Reliance Industries: To double its PET recycling capacity by setting up a recycled polyester staple fiber manufacturing facility in Andhra Pradesh. Srichakra Ecotex India will build and operate the new recycled PSF – Recron GreenGold and PET flakes wash-line in Andhra Pradesh for Reliance. The plant will help Reliance to more than double its recycling capacity to 5 billion post-consumer PET bottles.
• Dr. Reddy's Laboratories: Entered into a definitive agreement with BioDelivery Sciences International, Inc., to sell its U.S. and Canada territory rights for Elyxyb 25 mg/mL to the U.S.-based firm. Under the terms of agreement, Dr. Reddy's will receive $6 million upfront upon closing, followed by $9 million one year from closing. Further, it is eligible to receive event based, sales-based milestones and quarterly earn-out payments. “Elyxyb is an oral solution dosage form which makes it convenient for patients to take it immediately upon emergence of migraine attacks,” said Dr. Reddy's Laboratories CEO Erez Israeli.
• Shipping Corporation of India: Approved demerger of non-core assets into new company. The demerger is aimed at facilitating “an effective and efficient disinvestment” of Shipping Corporation of India by the government. Shipping Corp holders will get 1 share in the new company for every share they held in the state-run shipping company. The new company will be listed on BSE and NSE.
• Ion Exchange (India): Indian Oil Corporation has awarded an Engineering, Procurement, Construction and Commissioning contract of Rs 357.46 crore to the company to design and install effluent treatment plant on turnkey basis for its Para Xylene and Purified Terephthalic Acid complex project at Paradip, Orissa. The project is to be constructed and commissioned within 26 months from the date of Letter of Acceptance.
• Prakash Industries: Won Bhaskarpara Coal Mine in India auction.
• MMTC: The Supreme Court has passed an order in MMTC vs Anglo American Metallurgical Coal Pty Case reducing the interest component. Details are being worked out to know the impact of this decision, the company said. MMTC may need to make significant provision in the Accounts for 2020-21. The company is also exploring all legal remedies available.
• Shriram Transport Finance Company: Allotted 1000 secured NCDs of face value of Rs 10 lakh each, aggregating to Rs 100 crore on private placement basis. The proceeds of the issue will be utilised for financing of commercial vehicles, refinancing of existing debt and other general purposes of the company.
• Borosil Renewables: To increase production capacity of its third furnace (SG-3), being installed at its manufacturing facility at Bharuch, Gujarat, from 500 MT to 550 MT per day. The expansion will cost company Rs 600 crore
• Vodafone Idea: Kumar Mangalam Birla has stepped down as chairman of the company. The board accepted Birla’s request to step down as non-executive director and non-executive chairman of Vodafone Idea from August 4. Board has elected Himanshu Kapania as the non-executive chairman. Kapania is a nominee of the Aditya Birla Group. Board also appointed Sushil Agarwal, a nominee of Aditya Birla Group, as an additional director.
• SBI Life Insurance Company: CA Emerald Investments, an affiliate of Carlyle Group, to sell its entire 1.9% stake in SBI Life Insurance Company. It will sell 1.90 crore shares at Rs 1,130- Rs 1,136.85 apiece, as per term sheet. At the lower end, CA Emerald Investments will be able to raise Rs 2,147 crore ($289.4 million).
• Reliance Industries: To double its PET recycling capacity by setting up a recycled polyester staple fiber manufacturing facility in Andhra Pradesh. Srichakra Ecotex India will build and operate the new recycled PSF – Recron GreenGold and PET flakes wash-line in Andhra Pradesh for Reliance. The plant will help Reliance to more than double its recycling capacity to 5 billion post-consumer PET bottles.
• Dr. Reddy's Laboratories: Entered into a definitive agreement with BioDelivery Sciences International, Inc., to sell its U.S. and Canada territory rights for Elyxyb 25 mg/mL to the U.S.-based firm. Under the terms of agreement, Dr. Reddy's will receive $6 million upfront upon closing, followed by $9 million one year from closing. Further, it is eligible to receive event based, sales-based milestones and quarterly earn-out payments. “Elyxyb is an oral solution dosage form which makes it convenient for patients to take it immediately upon emergence of migraine attacks,” said Dr. Reddy's Laboratories CEO Erez Israeli.
• Shipping Corporation of India: Approved demerger of non-core assets into new company. The demerger is aimed at facilitating “an effective and efficient disinvestment” of Shipping Corporation of India by the government. Shipping Corp holders will get 1 share in the new company for every share they held in the state-run shipping company. The new company will be listed on BSE and NSE.
• Ion Exchange (India): Indian Oil Corporation has awarded an Engineering, Procurement, Construction and Commissioning contract of Rs 357.46 crore to the company to design and install effluent treatment plant on turnkey basis for its Para Xylene and Purified Terephthalic Acid complex project at Paradip, Orissa. The project is to be constructed and commissioned within 26 months from the date of Letter of Acceptance.
• Prakash Industries: Won Bhaskarpara Coal Mine in India auction.
• MMTC: The Supreme Court has passed an order in MMTC vs Anglo American Metallurgical Coal Pty Case reducing the interest component. Details are being worked out to know the impact of this decision, the company said. MMTC may need to make significant provision in the Accounts for 2020-21. The company is also exploring all legal remedies available.
• Shriram Transport Finance Company: Allotted 1000 secured NCDs of face value of Rs 10 lakh each, aggregating to Rs 100 crore on private placement basis. The proceeds of the issue will be utilised for financing of commercial vehicles, refinancing of existing debt and other general purposes of the company.
• Borosil Renewables: To increase production capacity of its third furnace (SG-3), being installed at its manufacturing facility at Bharuch, Gujarat, from 500 MT to 550 MT per day. The expansion will cost company Rs 600 crore
Godrej Industries Stock Prices..
Price Action Trading Setup | Breakout and Retest
Price Action Trading Setup | Breakout and Retest
Stocks to focus
• Reliance Industries Ltd: Reliance Strategic Business Ventures Ltd., a wholly owned subsidiary of the company, has invested Rs 20 crore in Neolync Solutions Pvt. Ltd. Reliance will invest Rs 40 crore more on Neolync achieving agreed milestones. Deal is expected to be complete by March 2023. Total investment will translate into 40% of Neolync. Neolync manufactures electronic products such as mobile phones, telecom products and computing devices. Reliance said that the investment is part of group’s overall 5G initiatives.
• Indiabulls Housing Finance: The company has voluntarily decided to set aside a sum equivalent to 75% of total maturity proceeds of its 6.375% secured USD bonds in multiple stages in a reserve fund. Total payment of Rs 27.30 billion ($368 million) will be made in May 2022 with Rs 20.47 billion of reserve fund and Rs 6.82 billion of final tranche paid by the company in May 22. The company had issued 6.375% secured US Dollar denominated bonds aggregating to $350 million in May 2019 for a tenor of 3 years. The principal portion of the bonds is fully hedged as per RBI norms, thereby ensuring the outstanding bonds are effectively a rupee liability to Rs 2,730 crore.
• Maruti Suzuki: Total production in July up 58.53% to 1,70,719 units Vs 1,07,687 units last year.
• Force Motors: The company’s total production in July stood at 2,046 units. It reported domestic sales of 1,607 units and exports of 213 units.
• GEE: To consider bonus issue on August 11.
• Minda Industries: Approved closure of QIP on August 5 and issue price of Rs 720 per share. The issue price is at discount of 2.02% to the floor price of Rs 734.84 per share.
• BL Kashyap & Sons: Has been awarded new projects worth Rs 189.85 crore. The total order inflow in FY22 now stands at Rs 694.02 crore. The company has received a concrete & block work package worth Rs 105.02 crore and a civil & block work package worth Rs 84.83 crore at Bengaluru.
• Reliance Industries Ltd: Reliance Strategic Business Ventures Ltd., a wholly owned subsidiary of the company, has invested Rs 20 crore in Neolync Solutions Pvt. Ltd. Reliance will invest Rs 40 crore more on Neolync achieving agreed milestones. Deal is expected to be complete by March 2023. Total investment will translate into 40% of Neolync. Neolync manufactures electronic products such as mobile phones, telecom products and computing devices. Reliance said that the investment is part of group’s overall 5G initiatives.
• Indiabulls Housing Finance: The company has voluntarily decided to set aside a sum equivalent to 75% of total maturity proceeds of its 6.375% secured USD bonds in multiple stages in a reserve fund. Total payment of Rs 27.30 billion ($368 million) will be made in May 2022 with Rs 20.47 billion of reserve fund and Rs 6.82 billion of final tranche paid by the company in May 22. The company had issued 6.375% secured US Dollar denominated bonds aggregating to $350 million in May 2019 for a tenor of 3 years. The principal portion of the bonds is fully hedged as per RBI norms, thereby ensuring the outstanding bonds are effectively a rupee liability to Rs 2,730 crore.
• Maruti Suzuki: Total production in July up 58.53% to 1,70,719 units Vs 1,07,687 units last year.
• Force Motors: The company’s total production in July stood at 2,046 units. It reported domestic sales of 1,607 units and exports of 213 units.
• GEE: To consider bonus issue on August 11.
• Minda Industries: Approved closure of QIP on August 5 and issue price of Rs 720 per share. The issue price is at discount of 2.02% to the floor price of Rs 734.84 per share.
• BL Kashyap & Sons: Has been awarded new projects worth Rs 189.85 crore. The total order inflow in FY22 now stands at Rs 694.02 crore. The company has received a concrete & block work package worth Rs 105.02 crore and a civil & block work package worth Rs 84.83 crore at Bengaluru.